drugset / Trial / NCT06188338
A 56-day Clinical Study on Facial Skin Rejuvenation
RandomizedParallel-groupDouble-blindTreatment
Summary
This clinical trial aims to learn about the efficacy of MLYAAT-1002® (a proprietary anti-aging complex, MLYAAT is short for "multi-layer anti-ageing technology" ) in female subjects who have newly received the rejuvenation treatment by comparing visual clinical scores, skin attributes measurement and image analysis.
Timeline
- Start
- 2023-11-18
- Primary completion
- 2024-01-27
- Completion
- 2024-08-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MLYAAT-1002® | Unknown | 1 unknown | Topical |